Evidence-based guides on GLP-1 hair shedding, telogen effluvium, treatment options, and scalp health.
The FDA label lists alopecia. The data is clear. But many doctors still say 'it's just stress.' Here's why the disconnect exists and what to do about it.
2026-04-19 ArticleYour GP says ferritin is 'normal' at 30 ng/mL. Hair specialists want 70+. This gap explains why many GLP-1 users lose hair despite 'normal' blood work.
2026-04-19 ArticleHair loss is the #1 reason women quit GLP-1 meds. But stopping reverses the health benefits. Here's the data on both sides of the trade-off.
2026-04-19 ArticleWegovy data shows >20% weight loss = 5.3% hair loss vs 2.5% at <20%. Lowering the dose may help, but reduces efficacy. The data on both sides.
2026-04-19 ArticleBariatric surgery causes hair loss in 47-57% of patients. GLP-1 medications in 25-33%. Same mechanism, different scale. What bariatric patients learned first.
2026-04-18 ArticleWomen 45-64 face a triple hair loss driver: perimenopause, GLP-1 hormonal effects, and rapid weight loss TE. No competitor addresses this. Here's the research.
2026-04-18 ArticleMy doctor said hormones. My derm said weight loss. My hairstylist said both. For women 45+, GLP-1 and perimenopause hair loss overlap. Here's how to sort it out.
2026-04-18 ArticleTE causes temporary diffuse shedding. Androgenic alopecia causes permanent pattern thinning. GLP-1 users can have both. Here's how to tell the difference.
2026-04-18 ArticleTelogen effluvium is temporary hair shedding caused by physiological stress. Up to 50% of follicles enter resting phase at once. Here's the full explanation.
2026-04-18 ArticleRapid weight loss, nutritional depletion, hormonal shifts, possible follicular effects, and metabolic stress. The 5 mechanisms behind GLP-1 hair shedding.
2026-04-18 ComparisonRanked by evidence: topical peptide serums, saw palmetto, rosemary, minoxidil, Nutrafol, biotin. What works for GLP-1 telogen effluvium and what doesn't.
2026-04-18 ComparisonVegamour uses plant actives for general thinning. PD-5 Complex uses peptides + saw palmetto for GLP-1 telogen effluvium. A fair comparison.
2026-04-18 ArticleSURMOUNT-1 trial: 4.9-5.3% alopecia with tirzepatide vs 0.9% placebo. Women affected 14x more than men. Here's the complete data.
2026-04-17 ArticleThe Wegovy FDA label reports 3% alopecia vs 1% placebo. Real-world data suggests 25-33% of women. Full breakdown of the semaglutide evidence.
2026-04-17 ArticleZepbound (tirzepatide) caused hair loss in 7.1% of women vs 0.5% of men in clinical trials. The FDA label data explained.
2026-04-17 ArticleShedding slows at month 6-9. Baby hairs appear at month 3-6. Full density takes 6-12 months after shedding stops. A research-backed recovery guide.
2026-04-17 ArticleThe damage starts before you see shedding. Here's what the research says about preventing GLP-1 hair loss in months 1-4, before the shedding window opens.
2026-04-17 ArticleRosemary oil matched minoxidil 2% in a head-to-head RCT. Patel 2025 found +57% growth rate. But for GLP-1 hair loss, it covers about 20% of the problem.
2026-04-17 ArticleTopical saw palmetto reduced shedding 22% and increased density 7.6% in an RCT. It blocks DHT locally without systemic hormonal effects. Full evidence review.
2026-04-17 ArticleYes, GLP-1 hair loss is reversible for most women. Baby hairs appear at 3-6 months. Full density returns in 6-12 months. Here's the complete recovery data.
2026-04-17 ComparisonMinoxidil works but requires lifelong use. Peptide serums have growing RCT evidence for telogen effluvium. A fair comparison for GLP-1 users.
2026-04-17 ComparisonBiotin, collagen, Nutrafol, Viviscal, prenatal vitamins, essential oils, and generic multivitamins. Why they fail for GLP-1 telogen effluvium.
2026-04-17 ArticleNo high-quality RCT shows biotin helps telogen effluvium in non-deficient women. Here's what the evidence says and what works instead.
2026-04-16 ArticleYes. The FDA Wegovy label reports 3% vs 1% placebo. Real-world studies suggest 25-33% of women. Here's the full data breakdown.
2026-04-16 ArticleGLP-1 hair shedding typically lasts 3-12 months. Here's a detailed timeline with clinical data on when it starts, peaks, and stops.
2026-04-16 ArticleGLP-1 hair loss (telogen effluvium) is reversible for most women. But recovery takes 6-12 months. Here's what clinical data says about the timeline.
2026-04-16 ArticleHair loss is the #1 reason women quit GLP-1 medications. But stopping reverses the health benefits. Here's how to think about the trade-off.
2026-04-16 ArticleBiotin, Nutrafol, rosemary oil, minoxidil, peptide serums, PRP. Here's what the published research says about each one for GLP-1 telogen effluvium.
2026-04-16 ComparisonNutrafol is an oral supplement for genetic thinning. PD-5 Complex is a topical peptide serum for GLP-1 shedding. Different products for different problems.
2026-04-16 ComparisonGLP-1 medications suppress appetite and reduce gut absorption. Here's why topical scalp treatments may work better than oral supplements for GLP-1 hair loss.
2026-04-16 GuideGLP-1 medications cause hair loss in 25-33% of women. Here's what the clinical data shows, why it happens, how long it lasts, and what actually helps.
2026-04-15 GuideOzempic causes hair loss in up to 25-33% of women. The FDA label says 3%. Here's what the real-world data shows and what you can do about it.
2026-04-15 GuideHair growth peptides like GHK, sh-Polypeptide-9, and copper peptides have real clinical data. Here's what the RCTs show, how they work, and who they help.
2026-04-15 GuideTelogen effluvium causes temporary hair shedding. Here's what published research shows about treatment options, recovery timelines, and what actually works.
2026-04-15